About Legend Capital
Legend Capital is a private equity firm founded in 2001. It is primarily based in Haidian, China. As of Aug 2026, Legend Capital is an active investor with a portfolio of 484 companies, comprising 484 funding rounds and 2 acquisitions. In the last 12 months, it has participated in 26 funding rounds. The firm primarily invests in companies based in China and United States. Its portfolio is spread across a wide range of sectors from Consumer to Life Sciences. Its latest investment was a $***** Series A round in Liangyi Wanxiang on Jul 19, 2026 which also saw participation from Shunwei Capital, iFLYTEK and other investors.
Overall Legend Capital portfolio has seen 11 unicorns, 63 IPOs and 21 acquisitions including key companies like DiDi, WuXi AppTec and Bilibili. A lot of funds co-invest with Legend Capital, with names like DCM Ventures sharing a substantial percentage of its portfolio.
Legend Capital has a team of 37 people, including 23 partners.
Key Metrics
Founded Year
2001
Location
Haidian, China
Portfolio Companies
Portfolio Sectors
Portfolio Locations
Investment Deals
Legend Capital's Portfolio
Legend Capital has a portfolio of 484 companies. They have invested in a total of 484 companies. Their most recent investment was in Liangyi Wanxiang (Series A round) on Jul 19, 2026. Here are the most recent investments by Legend Capital:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Jul 19, 2026 | Series A | 7880 | ||
Jul 06, 2026 | Angel | 9678 | ||
Jul 01, 2026 | Angel | 8395 | ||
Jun 03, 2026 | Series A | 1504 |
Legend Capital has acquired 2 companies. Their most recent acquisition was of Lexmark on Dec 24, 2024. Here are the most recent acquisitions by Legend Capital:
Acquisition Date | Company | Short Description | Total Funding | Founded Year |
|---|---|---|---|---|
Dec 24, 2024 | Provider of IoT and cloud-enabled imaging products for businesses | - | 1991 | |
Jul 26, 2018 | Developer of wearable devices and digital health management platform solutions | $20M | 2011 |
Here is the portfolio snapshot of Legend Capital:
Investments by Year
The maximum number of investments were made in 2022
Portfolio by Location
Companies are primarily in China and United States
Portfolio by Sector
Companies are primarily in Consumer
Team profile of Legend Capital
Legend Capital has a team of 37 members including 23 Partners and 5 Principals located in China, United States and 1 more location. Legend Capital's team does not sit on the board of any company as of now.Here is a list of top team members in Legend Capital:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Shanghai | - | ||
Partner | - | - | ||
Partner | China | - | ||
Partner | China | - | ||
Partner | China | - | ||
Partner | China | - | ||
Partner | Beijing | - | ||
Partner | Jing an | - | ||
Partner | - | - | ||
Partner | China | - |
Co-investors of Legend Capital
Over the past 25 years, 445 investors have co-invested in Legend Capital's portfolio companies.
- Top Co-investors of Legend Capital: 445 investors entered a company along with Legend Capital. These include investors like DCM Ventures (8 companies).
Legend Capital News
•
•
OIO Innovator Guanglianxinke Secures Nearly 500 Million Yuan in FundingEastmoney•Jun 03, 2026•Verity Ventures, Legend Capital
•
Chinese eVTOL startup Volant raises $148m series C+Tech in Asia•May 29, 2026•Volant Aerotech, China Internet Investment Fund, China Life Insurance, CoStone Capital and 3 others
•
Liangyi Wanxiang Completes A Round of 100 Million Yuan FinancingEastmoney•Apr 08, 2026•iFLYTEK, Legend Capital, Shunwei Capital, Legend Capital and 5 others
•
VITURE Raises Another $100M, Surpassing $200M in Six MonthsPR Newswire•Feb 26, 2026•VITURE, Legend Holdings, Bertelsmann, Legend Capital and 1 other
•
China's X Square Robot Tech Secures $143M in Series A++ Funding Led by Alibaba Cloud, Meituan & MoreCaproasia•Jan 13, 2026•X Square Robot, HSG, Legend Star, Alibaba Cloud and 7 others
•
•
Obita Raises Nearly US$30M Across Seed and Pre-A RoundsFinSMEs•Jan 12, 2026•Obita, Mirana, Vision Plus Capital, Legend Capital and 1 other
•
Allink Biotherapeutics Closes $47M Series A Extension for Clinical ProgramsPR Newswire•Dec 16, 2025•Allink Biotherapeutics, Legend Capital, Lapam Capital, Yuanbio Venture Capital and 2 others
•
